A019175 Stock Overview
Manufactures and sells pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Shinpoong Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩24,150.00 |
| 52 Week High | ₩39,400.00 |
| 52 Week Low | ₩16,150.00 |
| Beta | 0.92 |
| 1 Month Change | 2.33% |
| 3 Month Change | 20.75% |
| 1 Year Change | -20.56% |
| 3 Year Change | -69.43% |
| 5 Year Change | 292.05% |
| Change since IPO | 1,175.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| A019175 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.4% | 1.9% | -0.3% |
| 1Y | -20.6% | 11.4% | 6.5% |
Return vs Industry: A019175 underperformed the KR Pharmaceuticals industry which returned 11.4% over the past year.
Return vs Market: A019175 underperformed the KR Market which returned 6.5% over the past year.
Price Volatility
| A019175 volatility | |
|---|---|
| A019175 Average Weekly Movement | 14.8% |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A019175's share price has been volatile over the past 3 months.
Volatility Over Time: A019175's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 828 | n/a | shinpoong.co.kr |
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products.
Shinpoong Pharmaceutical Co.,Ltd Fundamentals Summary
| A019175 fundamental statistics | |
|---|---|
| Market cap | ₩718.67b |
| Earnings (TTM) | -₩55.13b |
| Revenue (TTM) | ₩200.23b |
3.5x
P/S Ratio-12.7x
P/E RatioIs A019175 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A019175 income statement (TTM) | |
|---|---|
| Revenue | ₩200.23b |
| Cost of Revenue | ₩119.95b |
| Gross Profit | ₩80.28b |
| Other Expenses | ₩135.40b |
| Earnings | -₩55.13b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.08k |
| Gross Margin | 40.09% |
| Net Profit Margin | -27.53% |
| Debt/Equity Ratio | 16.6% |
How did A019175 perform over the long term?
See historical performance and comparison